AARTIPHARMFinancial ResultsBSE
Board Meeting Intimation for Approval Of Unaudited Standalone And Consolidated Financial Results For The Second Quarter And Half Year Ended September 30, 2026
Filed 9 October 2026 at 11:01 am · 1h ago
FILING SUBJECT
Board Meeting Intimation for Approval Of Unaudited Standalone And Consolidated Financial Results For The Second Quarter And Half Year Ended September 30, 2026